| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $106M | $96M | — | 10.7% | — |
| Op. Income | $9M | $10M | — | -8.2% | — |
| Gross Margin | 45.5% | 48.3% | — | -2.8pp | — |
| Net Margin | 3.4% | 12.2% | — | -8.8pp | — |
| EPS (Diluted) | $0.09 | $0.31 | — | -70.3% | — |
| Free Cash Flow | $15M | $6M | — | 177.4% | — |
| Item | Amount |
|---|---|
| REVENUE | $106M |
| Cost of Revenue | $58M |
| GROSS PROFIT | $48M |
| R&D Expenses | $9M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $30M |
| Other Expenses | $0 |
| Operating Expenses | $39M |
| Cost & Expenses | $97M |
| OPERATING INCOME | $9M |
| Interest Income | $2M |
| Interest Expense | $5M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $5M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $4M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $4M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $4M |
| D&A | $7M |
| EBIT | $10M |
| EBITDA | $17M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $106M |
| Cost of Revenue | $58M |
| GROSS PROFIT | $48M |
| R&D Expenses | $9M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $30M |
| Other Expenses | $0 |
| Operating Expenses | $39M |
| Cost & Expenses | $97M |
| OPERATING INCOME | $9M |
| Interest Income | $2M |
| Interest Expense | $5M |
| Other Income/Expenses | -$4M |
| INCOME BEFORE TAX | $5M |
| Income Tax Expense | $1M |
| Net Income from Continuing Ops | $4M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $4M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $4M |
| D&A | $7M |
| EBIT | $10M |
| EBITDA | $17M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $4M |
| Depreciation & Amortization | $7M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$501.5K |
| Other Non-Cash Items | $444.7K |
| Change in Working Capital | $7M |
| OPERATING CASH FLOW | $18M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $6M |
| Purchases of Investments | -$6M |
| Sales/Maturities of Investments | -$5M |
| Other Investing Activities | -$2M |
| NET CASH FROM INVESTING | -$13M |
| Net Debt Issuance | -$3M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$755.1K |
| NET CASH FROM FINANCING | -$3M |
| FREE CASH FLOW | $15M |
| Net Change in Cash | $6M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $258M |
| Short-Term Investments | $5M |
| Net Receivables | $128M |
| Inventory | $24M |
| Other Current Assets | $23M |
| TOTAL CURRENT ASSETS | $438M |
| PP&E (Net) | $22M |
| Goodwill | $0 |
| Intangible Assets | $169M |
| Long-Term Investments | $209.3K |
| Tax Assets | $0 |
| Other Non-Current Assets | $7M |
| TOTAL NON-CURRENT ASSETS | $198M |
| TOTAL ASSETS | $636M |
| Account Payables | $202M |
| Short-Term Debt | $3M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $48M |
| TOTAL CURRENT LIABILITIES | $256M |
| Long-Term Debt | $152M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $7M |
| Other Non-Current Liabilities | $10M |
| TOTAL NON-CURRENT LIABILITIES | $172M |
| TOTAL LIABILITIES | $428M |
| Common Stock | $9.0K |
| Additional Paid-In Capital | $230M |
| Retained Earnings | -$33M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $10M |
| Other Equity | -$9.0K |
| TOTAL STOCKHOLDERS' EQUITY | $207M |
| Minority Interest | $0 |
| TOTAL EQUITY | $208M |
| TOTAL LIABILITIES & EQUITY | $638M |
| Total Debt | $161M |
| Net Debt | -$97M |
